Capricor Therapeutics Inc
NASDAQ:CAPR

Watchlist Manager
Capricor Therapeutics Inc Logo
Capricor Therapeutics Inc
NASDAQ:CAPR
Watchlist
Price: 29.68 USD 2.7%
Market Cap: 1.4B USD

Wall Street
Price Targets

CAPR Price Targets Summary
Capricor Therapeutics Inc

Wall Street analysts forecast CAPR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CAPR is 51.82 USD with a low forecast of 41.41 USD and a high forecast of 65.1 USD.

Lowest
Price Target
41.41 USD
40% Upside
Average
Price Target
51.82 USD
75% Upside
Highest
Price Target
65.1 USD
119% Upside
Capricor Therapeutics Inc Competitors:
Price Targets
HPHA
Heidelberg Pharma AG
134% Upside
CNTB
Connect Biopharma Holdings Ltd
195% Upside
FOLD
Amicus Therapeutics Inc
14% Upside
ATX
Amplia Therapeutics Ltd
243% Upside
CHRS
Coherus BioSciences Inc
331% Upside
CVAC
CureVac NV
11% Upside
1801
Innovent Biologics Inc
33% Upside
BVXP
Bioventix PLC
121% Upside

Revenue
Forecast

Revenue Estimate
Capricor Therapeutics Inc

For the last 13 years the compound annual growth rate for Capricor Therapeutics Inc's revenue is 24%. The projected CAGR for the next 4 years is 71%.

24%
Past Growth
71%
Estimated Growth
Estimates Accuracy
17%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Capricor Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Net Income
Forecast

Net Income Estimate
Capricor Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-92%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CAPR's stock price target?
Price Target
51.82 USD

According to Wall Street analysts, the average 1-year price target for CAPR is 51.82 USD with a low forecast of 41.41 USD and a high forecast of 65.1 USD.

What is Capricor Therapeutics Inc's Revenue forecast?
Projected CAGR
71%

For the last 13 years the compound annual growth rate for Capricor Therapeutics Inc's revenue is 24%. The projected CAGR for the next 4 years is 71%.

Back to Top